<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05116839</url>
  </required_header>
  <id_info>
    <org_study_id>MS/19.03.556</org_study_id>
    <nct_id>NCT05116839</nct_id>
  </id_info>
  <brief_title>Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gelin Adult Patients,</brief_title>
  <official_title>Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gel Laryngeal Mask for Minor Surgery in Adult Patients, a Prospective cross_over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction of Supra glottic airway devices (SAD) has revolutionized the airway management.&#xD;
      The first successful supraglottic airway device, the Laryngeal Mask Airway(LMA).The various&#xD;
      other SADs include ProSeal LMA, Intubating LMA and i-gel to overcome the limitations of&#xD;
      classic Laryngeal Mask Airway( c-LMA) The risk of aspiration with c-LMA is reported tobe&#xD;
      around 9% , pleaseboth the c-LMA and PLMA have cuff related complications. High cuff pressure&#xD;
      in laryngeal mask airways can cause damage to the mucosae on periglottic and supraglottic&#xD;
      structures .&#xD;
&#xD;
      Therefore, to overcome the limitations of Pro Seal Laryngeal Mask Airway (PLMA )a new and&#xD;
      cheaper SAD called i-gel was developed. i-gel is a novel and innovative, latex free&#xD;
      supraglottic device, made up of medical grade thermoplastic elastomer, which is soft, gel&#xD;
      like, transparent The number of manipulations required are more in PLMA than i gel resulting&#xD;
      in hemodynamic changes .The i-gel is comparable to PLMA insuring the airway during controlled&#xD;
      ventilation. It is better than PLMA in terms of ease of insertion.&#xD;
&#xD;
      Spontaneous breathing is the most popular mode of ventilation with the laryngeal mask airway&#xD;
      (LMA), but it provides less effective gas exchange than does positive pressure ventilation&#xD;
      (PPV) . The patients receiving sevoflurane anesthesia with unassisted ventilation have a&#xD;
      reduced rib cage contribution to ventilation, decreased tidal volume, and respiratory rate .&#xD;
&#xD;
      Pressure support ventilation (PSV) is a ventilator mode that is initiated by the patient and&#xD;
      synchronized with the patient's respiratory effort. And may improve gaseous exchange in&#xD;
      patients. In the intensive care unit, it is often considered the preferred mode for weaning&#xD;
      mechanical ventilation .PSV provides more effective gas exchange than does unassisted&#xD;
      ventilation with CPAP during anesthesia with the LMA while preserving hemodynamic&#xD;
      homeostasis.&#xD;
&#xD;
      The use of PSV versus CPAP with the Pro Seal laryngeal mask airway in anesthetized pediatric&#xD;
      patients revealed that PSV improved gaseous exchange and reduced work of breathing during&#xD;
      general anesthesia PSV via Pro- Seal laryngeal mask airway improves gaseous exchange and&#xD;
      ventilation in pediatric patients under general anesthesia more than spontaneous ventilation&#xD;
      .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients and Methods This prospective,cross over study will be conducted after obtaining&#xD;
      approval from the Institutional Review Board (IRB) of faculty of medicine Mansoura&#xD;
      University. A written informed consent will be obtained from all participants and the&#xD;
      duration of the study will be 2 - 6 months.&#xD;
&#xD;
      Participants:&#xD;
&#xD;
      38 Adult patients with American Society of Anesthesiologists (ASA) physical status (I - II&#xD;
      )of both sexes aged (18-65) years scheduled for minor surgery at Urology and Nephrology&#xD;
      centre (UNC) will be included in this study.&#xD;
&#xD;
      The Patients with a body mass index (BMI) &gt;40 or having obstructive air way disease will be&#xD;
      excluded.&#xD;
&#xD;
      All patients will be assessed on the day before surgery by detailed history thorough clinical&#xD;
      examination, and basal laboratory investigations [Complete blood count (CBC), Coagulation&#xD;
      profile (prothrombin time and INR), liver and renal function tests (liver enzymes, bilirubin,&#xD;
      albumin and s. creatinine], electrocardiograph (ECG) and echo cardiography when needed.&#xD;
&#xD;
      Anaesthesia Induction of anaesthesia with fentanyl 0.5µg/kg - propofol 1mg/kg prior for&#xD;
      insertion of device,primary success rate will be recorded.&#xD;
&#xD;
      Maintenance of anaesthesia by sevoflurane inhalation with minimal alveolar concentration&#xD;
      (MAC) 2%.&#xD;
&#xD;
      All patients will breath spontaneously from ventilators (Dragers - Primal - germany).&#xD;
&#xD;
      All patients will breath at the first 15 minutes with PSV:triggered by minute volume &lt;3&#xD;
      liter,with no frequency then the following 15 minutes ventilation will be changed to CPAP&#xD;
      mode at 10 cm H2o .&#xD;
&#xD;
      Monitoring: (basal&amp; every 3minutes)&#xD;
&#xD;
        1. Tidal volume (inspiratory &amp; expiratory).&#xD;
&#xD;
        2. End tidal co2.&#xD;
&#xD;
        3. Mean air way pressure.&#xD;
&#xD;
        4. Leakage %.&#xD;
&#xD;
        5. Respiratory rate .&#xD;
&#xD;
        6. Spo2.&#xD;
&#xD;
        7. Heart rate.&#xD;
&#xD;
        8. Blood pressure (mean arterial pressure). Adverse effects;Laryngeal spasm.Blood stained&#xD;
           device. .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2019</start_date>
  <completion_date type="Anticipated">October 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>a prospective cross_over study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard Tidal volume</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal&amp; every 3minutes)Tidal volume (inspiratory &amp; expiratory).on ventilator monitor in mil/ kilogram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard End tidal co2. on ventilator</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) End tidal co2. on ventilator ml/eq</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does CPAP as regard Mean air way pressure</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) Mean air way pressure.on ventilator mmhg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard Leakage %</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSVpressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) Leakage % on ventilator monitor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does CPAP as regard oxygen saturation.</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP.ventilation will be measured by Monitoring: (basal&amp; every 3minutes) oxygen saturation.on monitoring in %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective ventilation with PSV than does (CPAP) as regard respiratory rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Breathing of all patients at the first 15 minutes with PSV pressure support ventilation:triggered by minute volume &lt;3 liter,with no frequency then the following 15 minutes ventilation with CPAP .ventilation will be measured by Monitoring: (basal&amp; every 3minute)respiratory rate on monitor breath/ minute</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Ventilator Lung</condition>
  <arm_group>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients will breath at the first 15 minutes with PSV:triggered by minute volume &lt;3 Liter,with with no frequency .&#xD;
Monitoring: (basal&amp;every 3minutes)&#xD;
Tidal volume (inspiratory &amp; expiratory).&#xD;
End tidal co2.&#xD;
Mean air way pressure.&#xD;
Leakage %.&#xD;
Respiratory rate .&#xD;
Spo2.&#xD;
Heart rate.&#xD;
Blood pressure (mean arterial pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>then the following 15 minutes ventilation will be changed to CPAP mode at 10 cm H2o .&#xD;
Monitoring: (basal&amp;every 3minutes)&#xD;
Tidal volume (inspiratory &amp; expiratory).&#xD;
End tidal co2.&#xD;
Mean air way pressure.&#xD;
Leakage %.&#xD;
Respiratory rate .&#xD;
Spo2.&#xD;
Heart rate.&#xD;
Blood pressure (mean arterial pressure).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the first 15 minutes with pressure support ventilation</intervention_name>
    <description>PSV pressure support ventilation:triggered by minute volume &lt; 3 Liter ,with no frequency</description>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <other_name>lung mechanical ventilatory mode on mechanical ventilator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the following 15 minutes ventilation will be changed to continous positive air way pressureCPAP mode</intervention_name>
    <description>continous positive air way pressure CPAP mode at 10 cm H2o .</description>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
    <other_name>lung mechanical ventilatory mode on mechanical ventilator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>i gel air way</intervention_name>
    <description>supraglottic air way device</description>
    <arm_group_label>the first 15 minutes with PSV</arm_group_label>
    <arm_group_label>the following 15 minutes ventilation will be changed to CPAP mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with (ASA) physical status I - II years scheduled for minor surgery at&#xD;
             Urology and Nephrology centre (UNC) will be included in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The Patients with a body mass index (BMI) &gt;40 or having obstructive air way disease&#xD;
             will be excluded.•&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Golnar Se Hammouda, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanaa Ma El-Bendary, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Assistant Professor of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of Anesthesia Intensive Care Faculty of Medicine - Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bahaa Mo Ezz, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resident of Anesthesia Intensive Care Mansoura University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <phone>01002477789</phone>
    <email>marwaibr79@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marwa Ib Abdo, M.D</last_name>
    <phone>01556660553</phone>
    <email>marwaibr792000@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marwa Ibrahim Mohamed abdo</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marwa Ib Abdo, M.D</last_name>
      <phone>01002477789</phone>
      <email>marwaibr79@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Marwa Abdo, M.D</last_name>
      <phone>01556660553</phone>
      <email>marwaibr792000@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Barker P, Langton JA, Murphy PJ, Rowbotham DJ. Regurgitation of gastric contents during general anaesthesia using the laryngeal mask airway. Br J Anaesth. 1992 Sep;69(3):314-5.</citation>
    <PMID>1389850</PMID>
  </reference>
  <reference>
    <citation>Wong JG, Heaney M, Chambers NA, Erb TO, von Ungern-Sternberg BS. Impact of laryngeal mask airway cuff pressures on the incidence of sore throat in children. Paediatr Anaesth. 2009 May;19(5):464-9. doi: 10.1111/j.1460-9592.2009.02968.x. Epub 2009 Mar 5.</citation>
    <PMID>19281479</PMID>
  </reference>
  <reference>
    <citation>Levitan RM, Kinkle WC. Initial anatomic investigations of the I-gel airway: a novel supraglottic airway without inflatable cuff. Anaesthesia. 2005 Oct;60(10):1022-6.</citation>
    <PMID>16179048</PMID>
  </reference>
  <reference>
    <citation>Chauhan G, Nayar P, Seth A, Gupta K, Panwar M, Agrawal N. Comparison of clinical performance of the I-gel with LMA proseal. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):56-60. doi: 10.4103/0970-9185.105798.</citation>
    <PMID>23493414</PMID>
  </reference>
  <reference>
    <citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996 Jan;82(1):129-33.</citation>
    <PMID>8712387</PMID>
  </reference>
  <reference>
    <citation>Keller C, Sparr HJ, Luger TJ, Brimacombe J. Patient outcomes with positive pressure versus spontaneous ventilation in non-paralysed adults with the laryngeal mask. Can J Anaesth. 1998 Jun;45(6):564-7.</citation>
    <PMID>9669012</PMID>
  </reference>
  <reference>
    <citation>Tokioka H, Nagano O, Ohta Y, Hirakawa M. Pressure support ventilation augments spontaneous breathing with improved thoracoabdominal synchrony in neonates with congenital heart disease. Anesth Analg. 1997 Oct;85(4):789-93.</citation>
    <PMID>9322456</PMID>
  </reference>
  <reference>
    <citation>Farias JA, Frutos F, Esteban A, Flores JC, Retta A, Baltodano A, Alía I, Hatzis T, Olazarri F, Petros A, Johnson M. What is the daily practice of mechanical ventilation in pediatric intensive care units? A multicenter study. Intensive Care Med. 2004 May;30(5):918-25. Epub 2004 Mar 17.</citation>
    <PMID>15029473</PMID>
  </reference>
  <reference>
    <citation>Brimacombe J, Keller C, Hörmann C. Pressure support ventilation versus continuous positive airway pressure with the laryngeal mask airway: a randomized crossover study of anesthetized adult patients. Anesthesiology. 2000 Jun;92(6):1621-3.</citation>
    <PMID>10839911</PMID>
  </reference>
  <reference>
    <citation>von Goedecke A, Brimacombe J, Hörmann C, Jeske H-, Kleinsasser A, Keller C. Pressure support ventilation versus continuous positive airway pressure ventilation with the ProSeal laryngeal mask airway: a randomized crossover study of anesthetized pediatric patients. Anesth Analg. 2005 Feb;100(2):357-360. doi: 10.1213/01.ANE.0000143563.39519.FD.</citation>
    <PMID>15673856</PMID>
  </reference>
  <reference>
    <citation>Lim B, Pawar D, Ng O. Pressure support ventilation vs spontaneous ventilation via ProSeal™ laryngeal mask airway in pediatric patients undergoing ambulatory surgery: a randomized controlled trial. Paediatr Anaesth. 2012 Apr;22(4):360-4. doi: 10.1111/j.1460-9592.2012.03819.x.</citation>
    <PMID>22380745</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Marwa Ibrahim Mohamed Abdo,MD</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and Surgical Intensive Care-Faculty of Medicine - Mansoura University</investigator_title>
  </responsible_party>
  <keyword>Pressure support ventilation (CPAP) I gel</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

